Cargando…

Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning

BACKGROUND: We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT) in the detection of lymph node (LN) metastases in patients with known lung cancer compared to (18)F-fluorodeoxyglucose positron emission tomography (PET)/CT as a reference. METHODS: This retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorodetski, Boris, Becker, Philipp Hendrik, Baur, Alexander Daniel Jacques, Hartenstein, Alexander, Rogasch, Julian Manuel Michael, Furth, Christian, Amthauer, Holger, Hamm, Bernd, Makowski, Marcus, Penzkofer, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474782/ https://www.ncbi.nlm.nih.gov/pubmed/36104467 http://dx.doi.org/10.1186/s41747-022-00296-8

Ejemplares similares

A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [(18)F]FDG-PET/CT parameters
por: Rogasch, Julian M. M., et al.
Publicado: (2023)

Prostate Cancer Nodal Staging: Using Deep Learning to Predict (68)Ga-PSMA-Positivity from CT Imaging Alone
por: Hartenstein, A., et al.
Publicado: (2020)

CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations
por: Jensen, Laura J., et al.
Publicado: (2022)

Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
por: Rogasch, Julian M. M., et al.
Publicado: (2020)

The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases
por: Rogasch, Julian MM, et al.
Publicado: (2015)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
por: Rogasch, Julian M., et al.
Publicado: (2020)

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
por: Siefert, Jeffrey, et al.
Publicado: (2023)

Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making
por: Fehrenbach, Uli, et al.
Publicado: (2021)

(68)Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer
por: Damjanovic, Jonathan, et al.
Publicado: (2018)

ChatGPT: Can You Prepare My Patients for [(18)F]FDG PET/CT and Explain My Reports?
por: Rogasch, Julian M.M., et al.
Publicado: (2023)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer
por: Rudolph, Madhuri Monique, et al.
Publicado: (2020)

The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction
por: Rogasch, Julian MM, et al.
Publicado: (2014)

Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
por: Steffen, Ingo G, et al.
Publicado: (2013)

Selective Internal Radiation Therapy in Breast Cancer Liver Metastases: Outcome Assessment Applying a Prognostic Score
por: Schatka, Imke, et al.
Publicado: (2021)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition
por: Graef, Josefine, et al.
Publicado: (2020)

Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
por: Wetz, Christoph, et al.
Publicado: (2020)

The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [(177)Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis
por: Ruhwedel, Tristan, et al.
Publicado: (2021)

Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients
por: Zschaeck, Sebastian, et al.
Publicado: (2022)

Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases
por: Jung, Jinhong, et al.
Publicado: (2015)

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
por: Hussien, Amr Elsayed M., et al.
Publicado: (2015)

Secure data provenance and inference control semantic web
por: Thuraisingham, Bhavani M, et al.
Publicado: (2015)

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [(177)Lu]-DOTATATE
por: Wetz, Christoph, et al.
Publicado: (2019)

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation
por: Li, Yimin, et al.
Publicado: (2020)

Radiomics as an emerging tool in the management of brain metastases
por: Nowakowski, Alexander, et al.
Publicado: (2022)

PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study
por: Rogasch, Julian, et al.
Publicado: (2021)

CT findings of pathology proven benign metastasizing leiomyoma
por: Adair, Luther B.
Publicado: (2020)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

(18)F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
por: Xue, Xiu-qing, et al.
Publicado: (2022)

Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases
por: Jin, Zhicheng, et al.
Publicado: (2022)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases
por: Karapolat, İnanç, et al.
Publicado: (2012)

Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [(177)Lu]Lu-DOTATOC
por: Galler, Markus, et al.
Publicado: (2022)

Radiomics of the primary tumour as a tool to improve (18)F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer
por: De Bernardi, Elisabetta, et al.
Publicado: (2018)

Impact of (18)F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients
por: Münch, Stefan, et al.
Publicado: (2020)

Imaging biomarkers to stratify lymph node metastases in abdominal CT – Is radiomics superior to dual-energy material decomposition?
por: Mahmoudi, Scherwin, et al.
Publicado: (2022)

Radiomics-Based Analysis in the Prediction of Occult Lymph Node Metastases in Patients with Oral Cancer: A Systematic Review
por: Jiang, Serena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2dsoornssjaqgcu2b5f9drqq39